海翔药业：累计回购公司股份441万股

Core Viewpoint - On October 9, Haixiang Pharmaceutical announced a share buyback plan, indicating a strategic move to enhance shareholder value and confidence in the company's future performance [1] Summary by Categories Company Actions - Haixiang Pharmaceutical has repurchased a total of 4,410,000 shares, which represents 0.27% of the company's total share capital [1]